ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SUSAN MELTZER M.D.

12221-3 TULLAMORE ROAD MED. CARE CENTER AT MAYS CHAPEL

Timonium | Maryland | 21093

(410) 308-7808

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

7,562Medicare Part D Prescriptions Filled, Including Refills
$582K Total Retail Price of All Prescriptions
374 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 299 282
FUROSEMIDE 254 244
SIMVASTATIN 243 226
LEVOTHYROXINE SODIUM 205 183
AMLODIPINE BESYLATE 195 184
HYDROCODONE-ACETAMINOPHEN 156 141 S3
OMEPRAZOLE 156 127
DONEPEZIL HCL 155 155
LOSARTAN POTASSIUM 146 142
HYDROCHLOROTHIAZIDE 124 118
NAMENDA 116 116
PANTOPRAZOLE SODIUM 111 109
MIRTAZAPINE 104 104
ATENOLOL 104 98
METOPROLOL TARTRATE 102 89
SERTRALINE HCL 87 82
TRAZODONE HCL 87 68
PRAVASTATIN SODIUM 84 80
KLOR-CON M20 83 83
TAMSULOSIN HCL 83 83
TRAMADOL HCL 77 77
LABETALOL HCL 76 76
CITALOPRAM HBR 76 61
CLOPIDOGREL 75 75
JANTOVEN 75 75
VENLAFAXINE HCL ER 75 72
ATORVASTATIN CALCIUM 72 65
CYMBALTA 71 63
CRESTOR 69 69
SYNTHROID 63 59
LIDODERM 63 63
LOVASTATIN 60 60
GABAPENTIN 58 37
WARFARIN SODIUM 55 47
ZOLPIDEM TARTRATE 53 47
CIPROFLOXACIN HCL 52 50
METOPROLOL SUCCINATE 51 51
PAROXETINE HCL 50 44
ADVAIR DISKUS 50 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.